Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)

Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy

NCT05949333 ·Status: RECRUITING ·Phase: PHASE4

Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer

NCT01724866 ·Status: COMPLETED ·Phase: PHASE2

PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy

NCT02805153 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer

NCT04009941 ·Status: COMPLETED ·Phase: PHASE4

Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer

NCT04187898 ·Status: COMPLETED ·Phase: PHASE1

Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia

NCT01918241 ·Status: UNKNOWN ·Phase: PHASE2

Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy

NCT06711523 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide

NCT02953340 ·Status: COMPLETED ·Phase: PHASE3

A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

NCT00277160 ·Status: COMPLETED ·Phase: PHASE4

Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer Patients

NCT03376503 ·Status: COMPLETED ·Phase: PHASE1

Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia

NCT03294577 ·Status: UNKNOWN ·Phase: PHASE3

PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia

NCT02805205 ·Status: COMPLETED ·Phase: PHASE4

Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)

NCT00114764 ·Status: COMPLETED ·Phase: PHASE2

Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer

NCT04174742 ·Status: RECRUITING

Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF

NCT04554056 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients

NCT02104830 ·Status: COMPLETED ·Phase: PHASE3

Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel

NCT01126190 ·Status: COMPLETED ·Phase: PHASE3

Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3

NCT03102606 ·Status: COMPLETED ·Phase: PHASE3

The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia

NCT02761460 ·Status: UNKNOWN ·Phase: PHASE3

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

NCT01459653 ·Status: COMPLETED

An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)

NCT03433560 ·Status: COMPLETED

Plinabulin iv Solution in Prevention of TAC Induced Neutropenia

NCT04227990 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of YPEG-Filgrastim in Chemotherapy Patients

NCT01238562 ·Status: COMPLETED ·Phase: PHASE1

SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE)

NCT02643420 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy

NCT02005458 ·Status: COMPLETED ·Phase: PHASE2